Proxy Statement

Amphastar Pharmaceuticals, Inc. Filed 2015-04-08 Acc 0001171843-15-001880

Documents 1

2016-04-22 DEF 14A Proxy Statement
2015-04-10 4 Corp. SVP of Quality Assurance sold 10,000 shares at $15.79 ($157,900)
2015-04-10 4 Corp. Exec. VP of Operations sold 28,000 shares at $15.79 ($442,120)
2015-04-09 ARS Annual Report to Security Holders
2015-04-08 DEFA14A Proxy Materials
2015-04-08 DEF 14A Proxy Statement

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading def14a_040215.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…